Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vionic is a comfort-footwear and orthotic-inspired consumer health brand focused on supportive shoes, sandals, slippers, boots, and insoles. The company markets products designed to improve foot comfort and alignment, with particular emphasis on arch support and relief associated with plantar fasciitis and heel pain. Its products are built around proprietary biomechanical footbed technology marketed as VIO MOTION, and many products carry the American Podiatric Medical Association Seal of Acceptance. Vionic operates as a commercial footwear brand rather than a therapeutics developer, and it is part of Caleres following its 2018 acquisition. For a biotech analyst, this is best classified as a healthcare-adjacent commercial consumer brand, not a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vionic.